Results 161 to 170 of about 3,030,606 (198)

Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024. [PDF]

Euro Surveill
Böttcher S, Kreibich J, Wilton T, Saliba V, Blomqvist S, Al-Hello H, Savolainen-Kopra C, Wieczorek M, Gad B, Krzysztoszek A, Pintó RM, Cabrerizo M, Bosch A, Saxentoff E, Diedrich S, Martin J.   +15 more
europepmc   +1 more source

Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Excretion in an Infant with Severe Combined Immune Deficiency with Spillover to a Parent. [PDF]

Vaccines (Basel)
Mohanty MC, Govindaraj G, Ahmad M, Varose SY, Tatkare M, Shete A, Yadav S, Joshi Y, Yadav P, Sharma D, Kumar A, Verma H, Patil AP, Edavazhipurath A, Dhanasooraj D, Othayoth Kandy S, Puthenpurayil JM, Chakyar K, Melarcode Ramanan K, Madkaikar M.   +19 more
europepmc   +1 more source

Monitoring the evolution of vaccine-derived poliovirus in East and Southern African countries, 2010 - 2021. [PDF]

Pan Afr Med J
Byabamazima C, Masvikeni B, Katsande R, Manyanga D.   +3 more
europepmc   +1 more source

Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria. [PDF]

Vaccine X
Sun Y, Keskinocak P, Steimle LN, Kovacs SD, Wassilak SG.   +4 more
europepmc   +1 more source

Improvements of acute flaccid paralysis and measles surveillance performances in response to outbreak of circulating vaccine-derived poliovirus (2021-2022): the case of Southwest Ethiopia Region, Ethiopia. [PDF]

Pan Afr Med J
Denegetu AW, Birru TG, Asemahaegn EW.
europepmc   +1 more source

Early detection of vaccine-derived poliovirus outbreaks using nested PCR and nanopore sequencing in the Democratic Republic of Congo, 2021-2022

, 2023
Shaw A, Mampuela TK, Lofiko EL, Pratt C, Troman C, Bujaki E, O'Toole A, Akello J, Aziza AA, Lusamaki EK, Cigolo JM, Akonga M, Lay Y, Nsunda B, White B, Jorgensen D, Pukuta E, Riziki Y, Rankin K, Rambaut A, Ahuka-Mundeke S, Muyembe J, Martin J, Grassly N, Mbala-Kingebeni P.   +24 more
europepmc   +1 more source

Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria. [PDF]

J Infect Dis
Voorman A, Lyons H, Shuaib F, Adamu US, Korir C, Erbeto T, Bandyopadhyay AS, Okiror S.   +7 more
europepmc   +1 more source

Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative. [PDF]

Vaccines (Basel)
Halbrook M, Gadoth A, Mukadi P, Hoff NA, Musene K, Dzogang C, Sinai CS, Spencer D, Ngoie-Mwamba G, Tangney S, Salet F, Nyembwe M, Kambamba Nzaji M, Tambu M, Mbala P, Fuller T, Gerber SK, Kaba D, Muyembe-Tamfum JJ, Rimoin AW.   +19 more
europepmc   +1 more source

Re-emergence of vaccine-derived poliovirus in Nigeria: A call for vigilance

Clinical Epidemiology and Global Health
Aminu Shehu, Bashar Haruna Gulumbe, Abdulrakib Abdulrahim   +2 more
openaire   +2 more sources